Capricor Therapeutics Inc

NASDAQ:CAPR   3:59:40 PM EDT
4.00
-0.03 (-0.74%)
Earnings Announcements

Capricor Therapeutics Announces Positive Preclinical Data For Multivalent Exosome-mRNA Vaccine For Covid-19

Published: 11/09/2020 14:36 GMT
Capricor Therapeutics Inc (CAPR) - Capricor Therapeutics Announces Positive Preclinical Data for Multivalent Exosome-mrna Vaccine for Covid-19.
Capricor Therapeutics Inc - Capricor Scheduling Pre-ind Meeting With FDA to Discuss Clinical Strategy.
Capricor Therapeutics Inc - Q3 Loss per Share $0.20.
Revenue is expected to be $0.21 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.